Biblio
Applying the COM-B model to patient-reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020:e28216.
Cost analysis of bronchoalveolar lavage and respiratory tract biopsies in the diagnosis and management of suspected invasive fungal infection in children with cancer or who have undergone stem cell transplant. Pediatr Blood Cancer. 2019:e27598.
. INSPIRED Symposium Part 3: Prevention and Management of Pediatric CAR T Cell-Associated Emergent Toxicities. Transplant Cell Ther. 2023.
. Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023;14:1239132.
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(1):81-112.
A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors. J Clin Oncol. 2022:JCO2200230.
. Practice preferences for consolidative HSCT following tisagenlecleucel in children and young adults with B-ALL. Transplant Cell Ther. 2023.
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer. J Clin Oncol. 2023:JCO2301814.
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021:e29087.
. Successful medical management of a neonate with spontaneous splenic rupture and severe hemophilia A. Hematol Oncol Stem Cell Ther. 2016.
.